サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1356824

遺伝子検査市場レポート：2030年までの動向、予測、競合分析

Genetic Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

遺伝子検査市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

遺伝子検査の動向と予測

世界の遺伝子検査市場は、2024年から2030年までのCAGRが21.2%で、2030年までに推定273億米ドルに達すると予想されます。この市場の主な促進要因は、遺伝性疾患やがんの増加、個別化医療に対する意識の高まりと導入、消費者向け遺伝子検査キットの需要拡大です。世界の遺伝子検査市場の将来は、病院・診療所市場および診断ラボ市場における機会によって有望視されています。

遺伝子検査市場の洞察

  • Lucintelの予測では、出生前・新生児検査は、赤ちゃんの異常や症候群を特定するための利用が増加しているため、予測期間中に最も高い成長が見込まれます。
  • 病院・診療所は、新生児の遺伝性疾患のスクリーニングやがん患者の検査に遺伝子検査ガジェットのニーズが高まっているため、予測期間中に最も高い成長が見込まれます。
  • 北米は、技術的に高度な診断技術が存在すること、強固なヘルスケアインフラが利用可能であること、主要企業が存在することから、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の遺伝子検査市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の遺伝子検査市場動向（2018-2023）と予測（2024-2030）
  • 種類別の世界の遺伝子検査市場
    • 予知および発症前検査
    • キャリアテスト
    • 出生前および新生児検査
    • 診断テスト
    • 薬理ゲノム検査
    • その他
  • 製品別の世界の遺伝子検査市場
    • 消耗品
    • 装置
    • ソフトウェアとサービス
  • アプリケーション別の世界の遺伝子検査市場
    • 祖先と民族
    • 特性スクリーニング
    • 遺伝病保因者ステータス
    • 新生児スクリーニング
    • 健康とウェルネス-素因/リスク/傾向
  • 最終用途別の世界の遺伝子検査市場
    • 病院とクリニック
    • 診断研究所
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の遺伝子検査市場
  • 北米の遺伝子検査市場
  • 欧州の遺伝子検査市場
  • アジア太平洋遺伝子検査市場
  • その他地域遺伝子検査市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の遺伝子検査市場の成長機会
    • 製品別の世界の遺伝子検査市場の成長機会
    • アプリケーション別の世界の遺伝子検査市場の成長機会
    • 最終用途別の世界の遺伝子検査市場の成長機会
    • 地域別の世界の遺伝子検査市場の成長機会
  • 世界の遺伝子検査市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の遺伝子検査市場の能力拡大
    • 世界の遺伝子検査市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • 24 Genetics
  • Circle DNA
  • Tellmegen
  • 23andme
  • AncestryDNA
  • MyDNA
  • Everly Well
  • Igenomix
  • VitaGen
  • Myriad Genetics
目次

Genetic Testing Trends and Forecast

The future of the global genetic testing market looks promising with opportunities in the hospital & clinic and diagnostic laboratory markets. The global genetic testing market is expected to reach an estimated $27.3 billion by 2030 with a CAGR of 21.2% from 2024 to 2030. The major drivers for this market are increasing number of genetic diseases and cancers, rising awareness & adoption of personalized medicines, and growing demand for direct-to-consumer genetic testing kit.

A more than 150-page report is developed to help in your business decisions.

Genetic Testing by Segment

The study includes a forecast for the global genetic testing by type, product, application, end use, and region.

Genetic Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Predictive & Presymptomatic Testing
  • Carrier Testing
  • Prenatal & Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

Genetic Testing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Equipment
  • Software & Services

Genetic Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Ancestry & Ethnicity
  • Traits Screening
  • Genetic Disease Carrier Status
  • New Baby Screening
  • Health and Wellness-Predisposition/Risk/Tendency

Genetic Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Genetic Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Genetic Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies genetic testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the genetic testing companies profiled in this report include-

  • 24 Genetics
  • Circle DNA
  • Tellmegen
  • 23Andme
  • AncestryDNA
  • MyDNA
  • Everly Well
  • Igenomix
  • Vitagen
  • Myriad Genetics

Genetic Testing Market Insights

  • Lucintel forecasts that prenatal & newborn testing is expected to witness highest growth over the forecast period due to its rising usage to identify abnormality or syndromes in babies.
  • Hospital and clinic is expected to witness highest growth over the forecast perioddue to growing need for genetic testing gadgets to screen newborns for genetic disorders and test cancer patients.
  • North America is expected to witness highest growth over the forecast period due to existence of technologically advanced diagnostic techniques, availability of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global Genetic Testing Market

  • Market Size Estimates: Genetic testing market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Genetic testing market by various segments, such as by type, product, application, end use and region in terms of($B).
  • Regional Analysis: Genetic testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, products, applications, end uses, and region.s for the genetic testing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the genetic testing market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the genetic testing market size?

Answer: The global genetic testing market is expected to reach an estimated $27.3 billion by 2030.

Q.2. What is the growth forecast for genetic testing market?

Answer: The global genetic testing market is expected to grow with a CAGR of 21.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the genetic testing market?

Answer: The major drivers for this market are increasing number of genetic diseases and cancers, rising awareness & adoption of personalized medicines, and growing demand for direct-to-consumer genetic testing kit.

Q.4. What are the major segments for genetic testing market?

Answer: The future of the genetic testing market looks promising with opportunities in the hospital & clinic and diagnostic laboratory markets.

Q.5. Who are the key genetic testing market companies?

Answer: Some of the key genetic testing companies are as follows:

  • 24 Genetics
  • Circle DNA
  • Tellmegen
  • 23andme
  • AncestryDNA
  • MyDNA
  • Everly Well
  • Igenomix
  • VitaGen
  • Myriad Genetics

Q.6. Which genetic testing market segment will be the largest in future?

Answer: Lucintel forecasts that prenatal & newborn testing is expected to witness highest growth over the forecast period due to its rising usage to identify abnormality or syndromes in babies.

Q.7. In genetic testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of technologically advanced diagnostic techniques, availability of robust healthcare infrastructure, and presence of key players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the genetic testing market by type (predictive & presymptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others), product (consumables, equipment, and software & services), application (ancestry & ethnicity, traits screening, genetic disease carrier status, new baby screening, and health & wellness-predisposition/risk/tendency), end use (hospitals & clinics, diagnostic laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Genetic Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Genetic Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Genetic Testing Market by Type
    • 3.3.1: Predictive & Presymptomatic Testing
    • 3.3.2: Carrier Testing
    • 3.3.3: Prenatal & Newborn Testing
    • 3.3.4: Diagnostic Testing
    • 3.3.5: Pharmacogenomic Testing
    • 3.3.6: Others
  • 3.4: Global Genetic Testing Market by Product
    • 3.4.1: Consumables
    • 3.4.2: Equipment
    • 3.4.3: Software & Services
  • 3.5: Global Genetic Testing Market by Application
    • 3.5.1: Ancestry & Ethnicity
    • 3.5.2: Traits Screening
    • 3.5.3: Genetic Disease Carrier Status
    • 3.5.4: New Baby Screening
    • 3.5.5: Health and Wellness-Predisposition/Risk/Tendency
  • 3.6: Global Genetic Testing Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Diagnostic Laboratories
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Genetic Testing Market by Region
  • 4.2: North American Genetic Testing Market
    • 4.2.2: North American Genetic Testing Market by End Use: Hospitals & Clinics, Diagnostic Laboratories, and Others
  • 4.3: European Genetic Testing Market
    • 4.3.1: European Genetic Testing Market by Type: Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others
    • 4.3.2: European Genetic Testing Market by End Use: Hospitals & Clinics, Diagnostic Laboratories, and Others
  • 4.4: APAC Genetic Testing Market
    • 4.4.1: APAC Genetic Testing Market by Type: Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others
    • 4.4.2: APAC Genetic Testing Market by End Use: Hospitals & Clinics, Diagnostic Laboratories, and Others
  • 4.5: ROW Genetic Testing Market
    • 4.5.1: ROW Genetic Testing Market by Type: Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others
    • 4.5.2: ROW Genetic Testing Market by End Use: Hospitals & Clinics, Diagnostic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Genetic Testing Market by Type
    • 6.1.2: Growth Opportunities for the Global Genetic Testing Market by Product
    • 6.1.3: Growth Opportunities for the Global Genetic Testing Market by Application
    • 6.1.4: Growth Opportunities for the Global Genetic Testing Market by End Use
    • 6.1.5: Growth Opportunities for the Global Genetic Testing Market by Region
  • 6.2: Emerging Trends in the Global Genetic Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Genetic Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genetic Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: 24 Genetics
  • 7.2: Circle DNA
  • 7.3: Tellmegen
  • 7.4: 23andme
  • 7.5: AncestryDNA
  • 7.6: MyDNA
  • 7.7: Everly Well
  • 7.8: Igenomix
  • 7.9: VitaGen
  • 7.10: Myriad Genetics